| UniProt ID | S39AA_HUMAN | |
|---|---|---|
| UniProt AC | Q9ULF5 | |
| Protein Name | Zinc transporter ZIP10 | |
| Gene Name | SLC39A10 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 831 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
| Protein Description | May act as a zinc-influx transporter.. | |
| Protein Sequence | MKVHMHTKFCLICLLTFIFHHCNHCHEEHDHGPEALHRQHRGMTELEPSKFSKQAAENEKKYYIEKLFERYGENGRLSFFGLEKLLTNLGLGERKVVEINHEDLGHDHVSHLDILAVQEGKHFHSHNHQHSHNHLNSENQTVTSVSTKRNHKCDPEKETVEVSVKSDDKHMHDHNHRLRHHHRLHHHLDHNNTHHFHNDSITPSERGEPSNEPSTETNKTQEQSDVKLPKGKRKKKGRKSNENSEVITPGFPPNHDQGEQYEHNRVHKPDRVHNPGHSHVHLPERNGHDPGRGHQDLDPDNEGELRHTRKREAPHVKNNAIISLRKDLNEDDHHHECLNVTQLLKYYGHGANSPISTDLFTYLCPALLYQIDSRLCIEHFDKLLVEDINKDKNLVPEDEANIGASAWICGIISITVISLLSLLGVILVPIINQGCFKFLLTFLVALAVGTMSGDALLHLLPHSQGGHDHSHQHAHGHGHSHGHESNKFLEEYDAVLKGLVALGGIYLLFIIEHCIRMFKHYKQQRGKQKWFMKQNTEESTIGRKLSDHKLNNTPDSDWLQLKPLAGTDDSVVSEDRLNETELTDLEGQQESPPKNYLCIEEEKIIDHSHSDGLHTIHEHDLHAAAHNHHGENKTVLRKHNHQWHHKHSHHSHGPCHSGSDLKETGIANIAWMVIMGDGIHNFSDGLAIGAAFSAGLTGGISTSIAVFCHELPHELGDFAVLLKAGMTVKQAIVYNLLSAMMAYIGMLIGTAVGQYANNITLWIFAVTAGMFLYVALVDMLPEMLHGDGDNEEHGFCPVGQFILQNLGLLFGFAIMLVIALYEDKIVFDIQF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 44 | Phosphorylation | HRQHRGMTELEPSKF HHHHCCCCCCCCCHH | 40.00 | - | |
| 49 | Phosphorylation | GMTELEPSKFSKQAA CCCCCCCCHHHHHHH | 36.64 | - | |
| 49 | O-linked_Glycosylation | GMTELEPSKFSKQAA CCCCCCCCHHHHHHH | 36.64 | OGP | |
| 50 | Ubiquitination | MTELEPSKFSKQAAE CCCCCCCHHHHHHHH | 65.46 | 21890473 | |
| 52 | Phosphorylation | ELEPSKFSKQAAENE CCCCCHHHHHHHHHH | 27.82 | - | |
| 53 | Ubiquitination | LEPSKFSKQAAENEK CCCCHHHHHHHHHHH | 47.27 | - | |
| 66 | Ubiquitination | EKKYYIEKLFERYGE HHHHHHHHHHHHHCC | 49.25 | 21890473 | |
| 83 | Ubiquitination | RLSFFGLEKLLTNLG CEEEEHHHHHHHHCC | 41.88 | 21890473 | |
| 112 | Ubiquitination | GHDHVSHLDILAVQE CCCCCCHHHEEEEEC | 3.22 | - | |
| 139 | N-linked_Glycosylation | HNHLNSENQTVTSVS CCCCCCCCCEEEEEE | 42.52 | UniProtKB CARBOHYD | |
| 141 | O-linked_Glycosylation | HLNSENQTVTSVSTK CCCCCCCEEEEEECC | 37.01 | OGP | |
| 159 | O-linked_Glycosylation | KCDPEKETVEVSVKS CCCCCCCEEEEEEEC | 32.79 | OGP | |
| 198 | N-linked_Glycosylation | NNTHHFHNDSITPSE CCCCCCCCCCCCHHH | 43.72 | UniProtKB CARBOHYD | |
| 210 | O-linked_Glycosylation | PSERGEPSNEPSTET HHHCCCCCCCCCCCC | 49.91 | 55830831 | |
| 214 | O-linked_Glycosylation | GEPSNEPSTETNKTQ CCCCCCCCCCCCCCH | 32.47 | OGP | |
| 215 | O-linked_Glycosylation | EPSNEPSTETNKTQE CCCCCCCCCCCCCHH | 58.50 | OGP | |
| 218 | N-linked_Glycosylation | NEPSTETNKTQEQSD CCCCCCCCCCHHHHC | 38.86 | UniProtKB CARBOHYD | |
| 248 | O-linked_Glycosylation | NENSEVITPGFPPNH CCCCCCCCCCCCCCC | 23.64 | 55829247 | |
| 323 | Phosphorylation | VKNNAIISLRKDLNE CCCCEEEEEECCCCC | 18.93 | 29691806 | |
| 339 | N-linked_Glycosylation | DHHHECLNVTQLLKY CCHHHHCCHHHHHHH | 46.58 | UniProtKB CARBOHYD | |
| 346 | Phosphorylation | NVTQLLKYYGHGANS CHHHHHHHHCCCCCC | 18.04 | 30576142 | |
| 347 | Phosphorylation | VTQLLKYYGHGANSP HHHHHHHHCCCCCCC | 10.89 | 24043423 | |
| 353 | Phosphorylation | YYGHGANSPISTDLF HHCCCCCCCCCHHHH | 24.07 | 30576142 | |
| 356 | Phosphorylation | HGANSPISTDLFTYL CCCCCCCCHHHHHHH | 21.18 | 24043423 | |
| 357 | Phosphorylation | GANSPISTDLFTYLC CCCCCCCHHHHHHHH | 37.12 | 24043423 | |
| 361 | Phosphorylation | PISTDLFTYLCPALL CCCHHHHHHHHHHHH | 23.92 | 30576142 | |
| 362 | Phosphorylation | ISTDLFTYLCPALLY CCHHHHHHHHHHHHH | 10.04 | 24043423 | |
| 369 | Phosphorylation | YLCPALLYQIDSRLC HHHHHHHHHHCCHHH | 12.31 | 24043423 | |
| 373 | Phosphorylation | ALLYQIDSRLCIEHF HHHHHHCCHHHHHHH | 28.87 | 24043423 | |
| 390 | Ubiquitination | LLVEDINKDKNLVPE HHHHHHHCCCCCCCH | 71.11 | 21890473 | |
| 435 | S-palmitoylation | VPIINQGCFKFLLTF HHHHCCHHHHHHHHH | 2.12 | 29575903 | |
| 533 | Ubiquitination | GKQKWFMKQNTEEST CCCCCCHHCCCCCCC | 30.81 | 21890473 | |
| 536 | Phosphorylation | KWFMKQNTEESTIGR CCCHHCCCCCCCHHH | 38.34 | 23401153 | |
| 539 | Phosphorylation | MKQNTEESTIGRKLS HHCCCCCCCHHHHHC | 21.06 | 29255136 | |
| 540 | Phosphorylation | KQNTEESTIGRKLSD HCCCCCCCHHHHHCC | 30.63 | 23401153 | |
| 544 | Ubiquitination | EESTIGRKLSDHKLN CCCCHHHHHCCCCCC | 47.32 | - | |
| 546 | Phosphorylation | STIGRKLSDHKLNNT CCHHHHHCCCCCCCC | 40.48 | 25159151 | |
| 549 | Ubiquitination | GRKLSDHKLNNTPDS HHHHCCCCCCCCCCC | 58.88 | - | |
| 553 | Phosphorylation | SDHKLNNTPDSDWLQ CCCCCCCCCCCCCCC | 27.65 | 25159151 | |
| 556 | Phosphorylation | KLNNTPDSDWLQLKP CCCCCCCCCCCCCCC | 31.71 | 22199227 | |
| 562 | Ubiquitination | DSDWLQLKPLAGTDD CCCCCCCCCCCCCCC | 25.65 | 21890473 | |
| 567 | Phosphorylation | QLKPLAGTDDSVVSE CCCCCCCCCCCCCCH | 30.90 | 30576142 | |
| 570 | Phosphorylation | PLAGTDDSVVSEDRL CCCCCCCCCCCHHHC | 27.51 | 25159151 | |
| 573 | Phosphorylation | GTDDSVVSEDRLNET CCCCCCCCHHHCCCC | 31.46 | 25159151 | |
| 580 | Phosphorylation | SEDRLNETELTDLEG CHHHCCCCCCCCCCC | 34.91 | 29255136 | |
| 583 | Phosphorylation | RLNETELTDLEGQQE HCCCCCCCCCCCCCC | 32.10 | 30266825 | |
| 591 | Phosphorylation | DLEGQQESPPKNYLC CCCCCCCCCCCCEEE | 42.01 | 19664994 | |
| 594 | Ubiquitination | GQQESPPKNYLCIEE CCCCCCCCCEEEEEC | 62.70 | - | |
| 596 | Phosphorylation | QESPPKNYLCIEEEK CCCCCCCEEEEECEE | 14.74 | 30266825 | |
| 608 | Phosphorylation | EEKIIDHSHSDGLHT CEEEECCCCCCCCEE | 22.42 | 29449344 | |
| 610 | Phosphorylation | KIIDHSHSDGLHTIH EEECCCCCCCCEEHH | 36.07 | 29449344 | |
| 615 | Phosphorylation | SHSDGLHTIHEHDLH CCCCCCEEHHHHHHH | 29.13 | 29449344 | |
| 634 | Phosphorylation | NHHGENKTVLRKHNH CCCCCCCEECCCCCC | 36.03 | 24719451 | |
| 638 | Ubiquitination | ENKTVLRKHNHQWHH CCCEECCCCCCCCCC | 44.60 | - | |
| 648 | Phosphorylation | HQWHHKHSHHSHGPC CCCCCCCCCCCCCCC | 27.91 | 29449344 | |
| 651 | Phosphorylation | HHKHSHHSHGPCHSG CCCCCCCCCCCCCCC | 25.39 | 29449344 | |
| 734 | Phosphorylation | TVKQAIVYNLLSAMM CHHHHHHHHHHHHHH | 8.25 | 23879269 | |
| 743 | Phosphorylation | LLSAMMAYIGMLIGT HHHHHHHHHHHHHHH | 4.70 | 23879269 | |
| 750 | Phosphorylation | YIGMLIGTAVGQYAN HHHHHHHHHHHHHHH | 15.92 | 23879269 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of S39AA_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S39AA_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S39AA_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of S39AA_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-553, AND MASSSPECTROMETRY. | |